explore -WSS

explore

author：fashion 2025-09-02 22:02:06 - browse：5914

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Stanford president faces new allegations over 1999 paper

WSS

7 more heat

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Wegovy trial has doctors encouraged over new possibilities

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Judge rejects Trump's request to move Stormy Daniels hush

Emergent cuts jobs, executive role in business shake

Wikipedia

explore

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

At least 13 dead in Texas as scorching temps continue

Why Congress must ban federal programs from using QALYs

The cancer drug shortage isn’t new — and neither are the solutions

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Jerome Adams on the need for new antivirals for Covid

Divers poised to search for children washed away in Pennsylvania flash flood

23andMe had bad news about my health. I wish a person had delivered it

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

hotspot

DeSantis talks Trump, trans issues and 'what wokeness is'

How to use technology to prevent future drug shortages

Driven by the pandemic, applicants flood public health schools

What to know about Virgin Galactic's 1st mission taking paying customers to space

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

7 more heat

hotspot

hotspot

focus

focus